Shares of financial data provider FactSet (NYSE:FDS) jumped 3.3% in the morning session after UBS upgraded its rating on the company's stock from 'Neutral' to 'Buy', viewing the recent steep sell-off ...
Zacks Investment Research on MSN
Why FactSet Research (FDS) is a top momentum stock for the long term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Key differences between Corporate FDs and Bank FDs: Now, let's take a look at the differences between corporate FDs and bank FDs according to the information provided by Nirmal Bang's website. Fixed ...
Zacks.com on MSN
Here's Why You Should Retain FactSet Stock in Your Portfolio Now
FactSet Research Systems FDS stock has risen 4% in the past three months against the industry’s 8.4% decline. In the same ...
Baron Funds, an investment management company, released its “Baron Focused Growth Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Fund delivered strong ...
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their ...
Omnicell is growing its portfolio of medication management solutions and adherence tools. The Mountain View, Calif.-based company has entered into a definitive agreement with pharmacy software ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback